Biology of Osteosarcoma (BOOST) Registry and Biobank

Recruiting

• Conditions: Osteosarcoma

• Registration Number: NCT03225872
• Lead Sponsor: University of Minnesota

Brief Summary

Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.

Detailed Description

Summary to include:

1. Samples of saliva, blood and/or other stored material such as slides or leftover diagnostic material. If available the investigator may ask you for deciduous (baby) teeth.

2. Questionnaire information, including health history, growth and development, physical activity and family medical history information.

3. If you have been diagnosed with a osteosarcoma or another condition the investigator is interested inthe investigator will ask you release medical record information relating to diagnosis and treatment of osteosarcoma, other cancers, blood disorders, and similar conditions. If this step applies to you then you will be asked to sign a separate form.

4. You may be asked to contact your biological parents and full biological siblings to ask them about participating in the study.

5. If you agree you may be contacted in the future. You will be able to decline any future information or studies at any point.

Study Timeline

• Study Start: 2017-01-03
• Study First Submitted: 2017-07-19
• Study First Submitted QC: 2017-07-20
• Study First Posted: 2017-07-21
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-06
• Last Update Posted: 2024-10-08
• Primary Completion: 2050-12
• Study Completion: 2050-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma (ICCC 9180-9200)

Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with osteosarcoma (ICCC 9180-9200)

Read More

Exclusion Criteria

• Does not understand English.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determine if genes can determine osteosarcoma	Baseline	To do this the investigator will compare the genes of people with osteosarcoma to the genes of people who do not have these conditions.

Trial Locations

Locations (1)

Masonic Cancer Center; 🇺🇸 Minneapolis, Minnesota, United States